Pacemaker study for atrial fibrillation
Part of Heart & circulation clinical trials.
This study looks at how dual-chamber pacemakers affect atrial fibrillation (an irregular heartbeat). It aims to understand the benefits and risks of this type of pacemaker in managing this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You need to have (or be getting) a dual-chamber pacemaker, which paces both the upper and lower chambers of the heart.
- You must be able to give your informed consent to join the study.
- You should be willing to participate in long-term follow-up visits.
- You cannot have a single-chamber pacemaker or a biventricular (CRT) device at the start of the study.
- You must not have a life expectancy of less than one year due to other medical conditions, and you must be able to attend follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of pacemaker for people with atrial fibrillation who are scheduled for a procedure that disconnects the heart's natural electrical pathway. It may help improve symptoms and heart function.
This study compares two different ways of placing a pacemaker lead to see which one better helps heart function and reduces future heart problems in people with sick sinus syndrome.
This study compares two types of pacemaker pacing methods in people with heart block and normal heart pumping function. It looks at how often short bursts of fast heart rhythm occur in the upper heart chambers, which may help improve long-term heart health.
This study creates a database to better predict who with a pacemaker or ICD will develop atrial fibrillation (an irregular heart rhythm). It may help your care team spot risk earlier and tailor monitoring sooner.
This study tests how a pacemaker affects blood flow and heart health in people with heart block. It aims to see if special pacing settings can improve how the heart works.
This study looks for patterns that can predict an abnormal heart rhythm called SCAF in people who have a pacemaker or defibrillator. The goal is to help doctors recognize risk earlier and respond sooner if it happens.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.